자동 유방 초음파 검사 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 최종 용도별, 지역별 및 부문별 전망(2026-2033년)

The global automated breast ultrasound market size was valued at USD 2.4 billion in 2025 and is projected to grow from USD 2.7 billion in 2026 to USD 7.3 billion by 2033, at a CAGR of 15.2% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 35.0% in 2025. The increasing prevalence of breast cancer owing to a rise in sedentary lifestyles, obesity, changes in eating habits, and rising alcohol consumption is expected to increase the risk of the disease. In addition, the demand for reliable identification of breast lesions in the early stage of cancer is encouraging major manufacturing companies to develop automated diagnosis methods. Furthermore, various other government initiatives and awareness programs are significant contributors to the growth of the market.

According to a report from the American Cancer Society, approximately 2.04 million people were diagnosed with cancer in 2025. In addition, a report published by the WHO in February 2025 noted about 3.2 million cases of breast cancer and 1.1 million deaths worldwide in 2024. The increase in breast cancer cases highlights the need for technologically advanced medical devices that facilitate easier and earlier detection compared to conventional methods. This demand is expected to drive growth in the market over the forecast period.

The survival rate for breast cancer is significantly higher when diagnosed in the early stages; however, it drops to around 25 percent when detected at later stages. An article from the Massachusetts Institute of Technology, published in July 2023, reported that MIT researchers have designed a wearable ultrasound device capable of detecting tumors at an early stage. Such technological advancements are likely to boost market growth further in the coming years.

Various initiatives by government institutions and companies have raised awareness about breast cancer among both men and women, positively impacting market growth. For example, the WHO launched a new roadmap for breast cancer to save 2.5 million lives from the disease by 2040. Similarly, the Ministry of Health and Family Welfare in India is providing financial assistance to individuals living below the poverty line who are suffering from diseases such as cancer through the Umbrella Scheme, Rashtriya Arogya Nidhi, and the Health Minister's Discretionary Grant.

Automated Breast Ultrasound Market Report Segmentation

This report forecasts revenue growth at global; regional; and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global automated breast ultrasound market report based on product, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

Automated Breast Volume Scanner

Automated Breast Ultrasound (ABUS)

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

Hospital

Diagnostics Imaging Laboratories

Others

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

North America

• U.S.
• Canada
• Mexico

Europe

• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway

Asia Pacific

• Japan
• China
• India
• Australia
• South Korea
• Thailand

Latin America

• Brazil
• Argentina

MEA

• South Africa
• Saudi Arabia
• UAE
• Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Automated Breast Ultrasound Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. Automated Breast Ultrasound Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. Automated Breast Ultrasound Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Automated Breast Ultrasound Market: Product Movement Analysis, 2025 & 2033 (USD Million)
• 4.3. Automated Breast Volume Scanner
  • 4.3.1. Automated Breast Volume Scanner Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Automated Breast Ultrasound (ABUS)
  • 4.4.1. Automated Breast Ultrasound (ABUS) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Automated Breast Ultrasound Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Automated Breast Ultrasound Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
• 5.3. Hospitals
  • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. Diagnostics Imaging Laboratories
  • 5.4.1. Diagnostics Imaging Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Others
  • 5.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Automated Breast Ultrasound Market: Regional Estimates & Trend Analysis

• 6.1. Automated Breast Ultrasound Market Share, By Region, 2025 & 2033 (USD Million)
• 6.2. North America
  • 6.2.1. North America Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.2.2. U.S.
    • 6.2.2.1. U.S. Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.2.3. Canada
    • 6.2.3.1. Canada Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.2.4. Mexico
    • 6.2.4.1. Mexico Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.3. Europe
  • 6.3.1. Europe Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. UK
    • 6.3.2.1. UK Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.3. Germany
    • 6.3.3.1. Germany Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.4. France
    • 6.3.4.1. France Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.5. Italy
    • 6.3.5.1. Italy Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.6. Spain
    • 6.3.6.1. Spain Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.7. Denmark
    • 6.3.7.1. Denmark Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.8. Sweden
    • 6.3.8.1. Sweden Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.9. Norway
    • 6.3.9.1. Sweden Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. Asia Pacific
  • 6.4.1. Asia Pacific Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.2. Japan
    • 6.4.2.1. Japan Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.3. China
    • 6.4.3.1. China Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.4. India
    • 6.4.4.1. India Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.5. South Korea
    • 6.4.5.1. South Korea Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.6. Thailand
    • 6.4.6.1. Thailand Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Latin America
  • 6.5.1. Latin America Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.2. Brazil
    • 6.5.2.1. Brazil Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.3. Argentina
    • 6.5.3.1. Argentina Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Middle East and Africa
  • 6.6.1. Middle East and Africa Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.2. South Africa
    • 6.6.2.1. South Africa Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.3. Saudi Arabia
    • 6.6.3.1. Saudi Arabia Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.4. UAE
    • 6.6.4.1. Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.5. Kuwait
    • 6.6.5.1. Kuwait Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis by Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Heat Map Analysis
• 7.4. Company Profiles
  • 7.4.1. GE HealthCare.
    • 7.4.1.1. Participant's Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Recent Developments/ Strategic Initiatives
  • 7.4.2. Koninklijke Philips N.V.
    • 7.4.2.1. Participant's Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Recent Developments/ Strategic Initiatives
  • 7.4.3. Siemens Healthcare Private Limited
    • 7.4.3.1. Participant's Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Recent Developments/ Strategic Initiatives
  • 7.4.4. CANON MEDICAL SYSTEMS CORPORATION
    • 7.4.4.1. Participant's Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Recent Developments/ Strategic Initiatives
  • 7.4.5. TELEMED Medical Systems srl
    • 7.4.5.1. Participant's Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Recent Developments/ Strategic Initiatives
  • 7.4.6. Hologic, Inc.
    • 7.4.6.1. Participant's Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Recent Developments/ Strategic Initiatives
  • 7.4.7. SuperSonic Imagine
    • 7.4.7.1. Participant's Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Recent Developments/ Strategic Initiatives
  • 7.4.8. Lunit Inc.
    • 7.4.8.1. Participant's Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Recent Developments/ Strategic Initiatives
  • 7.4.9. Delphinus Medical Technologies, Inc.
    • 7.4.9.1. Participant's Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Recent Developments/ Strategic Initiatives